Clinical Trial Update: A Phase Ib Study of Humanized Anti-VEGF Monoclonal Antibody (Sevacizumab) Injection Plus FOLFIRI in Chinese Patients With Metastatic Colorectal Cancer [Phase 1]

View source ↗

Summary

This document reports a Phase Ib/Phase 1 trial evaluating Sevacizumab, an anti-VEGF monoclonal antibody, in combination with FOLFIRI in Chinese patients with me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• Sevacizumab (sevacizumab)

Snippet

Sponsor: Jiangsu Simcere Pharmaceutical Co., Ltd. | Conditions: Metastatic Colorectal Cancer | Phase 1 | Status: UNKNOWN